HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path

Continue Your Learning

Posted by
HealthTree image
HealthTree
Last updated and reviewed on: March 31, 2025

Watch

  • Using MRD Adapted Strategy (MIDAS) to guide myeloma treatment | Sagar Lonial, MD, FACP | IMS 2024

Read 

  • Can Knowing Your MRD Status Help Guide Myeloma Treatment?
  • Is MRD Negativity the Goal of Myeloma Treatment?

View

User uploaded media

 

Related Content

  • Video Blood-Based MRD Testing Correlates With Bone Marrow Testing in Multiple Myeloma -EasyM | IMS 2026
  • Video Mass Spectrometry in Myeloma: Can a Blood Test Reduce Bone Marrow Biopsies? | IMS 2026
  • Video BETA - Can MRD testing be done on a blood sample instead of a bone marrow sample in multiple myeloma?
  • Video BETA - In the context of NGS-based MRD testing, what is a clonality (clonal) ID, why is it important, and at what point…
  • Video Blood-based Mass Spectrometry MRD Testing for Myeloma : EasyM | EHA 2026